CNR1 and myeloid sarcoma: More specifically, inflammatory disorders such as MS destroy the nucleus of the amygdala (CeA), and negatively impact on the circulating levels of opioids, and cannabinoids such as cannabinoids type 1 (CB1) and its receptor (CB1R).